These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 28125887)
21. Simplified Frailty Index as a Predictor of Adverse Outcomes in Total Hip and Knee Arthroplasty. Shin JI; Keswani A; Lovy AJ; Moucha CS J Arthroplasty; 2016 Nov; 31(11):2389-2394. PubMed ID: 27240960 [TBL] [Abstract][Full Text] [Related]
22. Impact of Cirrhosis on Resource Use and Inpatient Complications in Patients Undergoing Total Knee and Hip Arthroplasty. Newman JM; Schiltz NK; Mudd CD; Szubski CR; Klika AK; Barsoum WK J Arthroplasty; 2016 Nov; 31(11):2395-2401. PubMed ID: 27236746 [TBL] [Abstract][Full Text] [Related]
23. Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty. Wilson DG; Poole WE; Chauhan SK; Rogers BA Bone Joint J; 2016 Aug; 98-B(8):1056-61. PubMed ID: 27482017 [TBL] [Abstract][Full Text] [Related]
24. Early thromboembolic events ≤1week after fast-track total hip and knee arthroplasty. Jørgensen CC; Kehlet H; Thromb Res; 2016 Feb; 138():37-42. PubMed ID: 26826506 [TBL] [Abstract][Full Text] [Related]
25. Retrospective Evaluation of Postoperative Bleeding Events in Patients Receiving Rivaroxaban After Undergoing Total Hip and Total Knee Arthroplasty: Comparison with Clinical Trial Data. Wood RC; Stewart DW; Slusher L; El-Bazouni H; Cluck D; Freshour J; Odle B Pharmacotherapy; 2015 Jul; 35(7):663-9. PubMed ID: 26095331 [TBL] [Abstract][Full Text] [Related]
26. Comparison of US and Canadian Perioperative Outcomes and Hospital Efficiency After Total Hip and Knee Arthroplasty. Hart A; Bergeron SG; Epure L; Huk O; Zukor D; Antoniou J JAMA Surg; 2015 Oct; 150(10):990-8. PubMed ID: 26288005 [TBL] [Abstract][Full Text] [Related]
27. Intraoperative Hypothermia in Total Hip and Knee Arthroplasty. Frisch NB; Pepper AM; Rooney E; Silverton C Orthopedics; 2017 Jan; 40(1):56-63. PubMed ID: 27783839 [TBL] [Abstract][Full Text] [Related]
28. Effect of Type 2 Diabetes on In-Hospital Postoperative Complications and Mortality After Primary Total Hip and Knee Arthroplasty. Martínez-Huedo MA; Jiménez-García R; Jiménez-Trujillo I; Hernández-Barrera V; Del Rio Lopez B; López-de-Andrés A J Arthroplasty; 2017 Dec; 32(12):3729-3734.e2. PubMed ID: 28735804 [TBL] [Abstract][Full Text] [Related]
29. Risk of Ischemic Stroke After Perioperative Atrial Fibrillation in Total Knee and Hip Arthroplasty Patients. Khormaee S; Do HT; Mayr Y; Gialdini G; Kamel H; Lyman S; Cross MB J Arthroplasty; 2018 Sep; 33(9):3016-3019. PubMed ID: 29793849 [TBL] [Abstract][Full Text] [Related]
30. Deep vein thrombosis after total hip arthroplasty and total knee arthroplasty in patients with previous ischemic stroke. Qin J; Xu Z; Shi D; Chen D; Dai J; Teng H; Jiang Q Int J Low Extrem Wounds; 2013 Dec; 12(4):316-9. PubMed ID: 24043672 [TBL] [Abstract][Full Text] [Related]
31. Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty. Singh JA; Jensen MR; Harmsen WS; Gabriel SE; Lewallen DG Ann Rheum Dis; 2011 Dec; 70(12):2082-8. PubMed ID: 22021865 [TBL] [Abstract][Full Text] [Related]
32. Balancing Thromboprophylaxis and Bleeding in Total Joint Arthroplasty: Impact of Eliminating Enoxaparin and Predonation and Implementing Pneumatic Compression and Tranexamic Acid. Sharfman ZT; Campbell JC; Mirocha JM; Spitzer AI J Arthroplasty; 2016 Jun; 31(6):1307-1312. PubMed ID: 26781392 [TBL] [Abstract][Full Text] [Related]
33. A Canadian study of the cost-effectiveness of apixaban compared with enoxaparin for post-surgical venous thromboembolism prevention. Revankar N; Patterson J; Kadambi A; Raymond V; El-Hadi W Postgrad Med; 2013 Jul; 125(4):141-53. PubMed ID: 23933902 [TBL] [Abstract][Full Text] [Related]
34. New options for anticoagulation following total hip arthroplasty and total knee arthroplasty: new oral agents on the horizon. Amin A Hosp Pract (1995); 2012 Aug; 40(3):19-26. PubMed ID: 23086091 [TBL] [Abstract][Full Text] [Related]
35. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
36. In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty. Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P J Med Econ; 2012; 15(4):644-53. PubMed ID: 22356512 [TBL] [Abstract][Full Text] [Related]
37. [Evaluation and treatment of hemorrhage after hip and knee arthroplasty in the aged]. Chen LL; Wang WC; Mao XZ; Yu M; Zhu Q Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):316-9. PubMed ID: 17478944 [TBL] [Abstract][Full Text] [Related]
38. Comparative Epidemiology of Revision Arthroplasty: Failed THA Poses Greater Clinical and Economic Burdens Than Failed TKA. Bozic KJ; Kamath AF; Ong K; Lau E; Kurtz S; Chan V; Vail TP; Rubash H; Berry DJ Clin Orthop Relat Res; 2015 Jun; 473(6):2131-8. PubMed ID: 25467789 [TBL] [Abstract][Full Text] [Related]
39. Has the incidence of deep vein thrombosis in patients undergoing total hip/knee arthroplasty changed over time? A systematic review of randomized controlled trials. Xing KH; Morrison G; Lim W; Douketis J; Odueyungbo A; Crowther M Thromb Res; 2008; 123(1):24-34. PubMed ID: 18620740 [TBL] [Abstract][Full Text] [Related]
40. Impact of Gender on 30-Day Complications After Primary Total Joint Arthroplasty. Robinson J; Shin JI; Dowdell JE; Moucha CS; Chen DD J Arthroplasty; 2017 Aug; 32(8):2370-2374. PubMed ID: 28366312 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]